- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00799695
Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population
Diabetic retinopathy is the major cause of blindness in working age Americans, and screening for it is cost-effective. There are a quarter of a million people in Southeast Michigan with diabetes and pre-diabetes.
Only half of patients with diabetes are screened regularly for diabetic retinopathy, and this proportion has been difficult to increase despite various interventions. Previous research focused on HMO patient groups because preventative care was thought to decrease plan costs. In addition, it was administratively feasible to track patient-doctor interactions.
This project builds on published research and institutional experience to determine an effective method for increasing the screening rate, in a mobile, non-HMO population. It uses administrative methods and information technology infrastructures, such as large scale electronic medical records and patient demographic databases, to identify existing patients requiring examinations.
Patients were telephoned by a trained service representative who offered and scheduled firm examination appointment times.
Hypothesis: Annual screening rates for diabetic retinopathy can be substantially improved in non-HMO patient groups by directly contacting patients and scheduling firm appointment times.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Michigan
-
Detroit, Michigan, Forenede Stater, 48202
- Henry Ford Health System
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- were Henry Ford Health System patients,
- diabetic
- using the BCBSM payer plan
Exclusion Criteria:
- retina examination in prior year
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Enkelt
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
a change in the proportion of diabetic patients who acted as a result of the phone contact, and obtained a retina eye exam.
Tidsramme: 3 months
|
3 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Robert M Levine,, MD, Henry Ford Health System
Publikationer og nyttige links
Hjælpsomme links
- Michigan Diabetes Prevention and Control Program, 2005 Assessment of Diabetes Care System, Michigan Department of Community Health
- Michigan Diabetes Fact Pages 2006, 2004 prevalence, risk factors, mortality, hospitalization discharge and amputation data for Michigan, Michigan Department of Community Health
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- F10030
- 13.13PIRAP
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Diabetisk retinopati
-
Assiut UniversityUkendtom Vitreomacular Interface Abnormalities in Diabetic Retinopathy
Kliniske forsøg med phone call contact
-
Angelo BivianoAfsluttet
-
Indiana UniversityMayo Clinic; University of Minnesota; Regenstrief Institute, Inc.; Innovative...Ikke rekrutterer endnuDemens | Alzheimers sygdom | SøvnforstyrrelserForenede Stater
-
Gilead SciencesAfsluttet
-
Gilead SciencesAfsluttetLymfoide maligniteterHolland
-
Abbott Medical DevicesAfsluttetTypisk atrieflimrenForenede Stater, Canada
-
Central Hospital, Nancy, FranceAfsluttetSelvmord og selvskadeFrankrig
-
Assistance Publique - Hôpitaux de ParisCSL BehringAfsluttet
-
Youngstown State UniversityAfsluttet
-
Elixir Medical CorporationRekruttering
-
Tufts Medical CenterAmerican Contact Dermatitis Society (ACDS)AfsluttetAllergi | Dermatitis | Nældefeber | Patch test | Kontakt SensibiliseringForenede Stater